Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis.

Boilard E, Lai Y, Larabee K, Balestrieri B, Ghomashchi F, Fujioka D, Gobezie R, Coblyn JS, Weinblatt ME, Massarotti EM, Thornhill TS, Divangahi M, Remold H, Lambeau G, Gelb MH, Arm JP, Lee DM.

EMBO Mol Med. 2010 May;2(5):172-87. doi: 10.1002/emmm.201000072.

PMID:
20432503
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Phospholipase A2 in experimental allergic bronchitis: a lesson from mouse and rat models.

Mruwat R, Yedgar S, Lavon I, Ariel A, Krimsky M, Shoseyov D.

PLoS One. 2013 Oct 29;8(10):e76641. doi: 10.1371/journal.pone.0076641. eCollection 2013.

PMID:
24204651
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.

Morioka Y, Saiga A, Yokota Y, Suzuki N, Ikeda M, Ono T, Nakano K, Fujii N, Ishizaki J, Arita H, Hanasaki K.

Arch Biochem Biophys. 2000 Sep 1;381(1):31-42.

PMID:
11019817
[PubMed - indexed for MEDLINE]
4.

Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes.

Bidgood MJ, Jamal OS, Cunningham AM, Brooks PM, Scott KF.

J Immunol. 2000 Sep 1;165(5):2790-7.

PMID:
10946311
[PubMed - indexed for MEDLINE]
Free Article
5.

Group IIA secretory PLA2 inhibition by ursolic acid: a potent anti-inflammatory molecule.

Nataraju A, Raghavendra Gowda CD, Rajesh R, Vishwanath BS.

Curr Top Med Chem. 2007;7(8):801-9.

PMID:
17456043
[PubMed - indexed for MEDLINE]
6.
7.

Isoforms of secretory group two phospholipase A (sPLA2) in mouse ocular surface epithelia and lacrimal glands.

Wei Y, Pinhas A, Liu Y, Epstein S, Wang J, Asbell P.

Invest Ophthalmol Vis Sci. 2012 May 14;53(6):2845-55. doi: 10.1167/iovs.11-8684.

PMID:
22467583
[PubMed - indexed for MEDLINE]
Free Article
8.

sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model.

Wei Y, Epstein SP, Fukuoka S, Birmingham NP, Li XM, Asbell PA.

Invest Ophthalmol Vis Sci. 2011 Jul 1;52(7):4780-8. doi: 10.1167/iovs.10-6350.

PMID:
21519031
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Thyroid hormone status regulates the expression of secretory phospholipases.

Sharma P, Levesque T, Boilard E, Park EA.

Biochem Biophys Res Commun. 2014 Jan 31;444(1):56-62. doi: 10.1016/j.bbrc.2014.01.003. Epub 2014 Jan 16.

PMID:
24440706
[PubMed - indexed for MEDLINE]
10.

Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice.

Thwin MM, Douni E, Arjunan P, Kollias G, Kumar PV, Gopalakrishnakone P.

Arthritis Res Ther. 2009;11(5):R138. doi: 10.1186/ar2810. Epub 2009 Sep 18.

PMID:
19765281
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Inhibition of extracellular release of proinflammatory secretory phospholipase A2 (sPLA2) by sulfasalazine: a novel mechanism of anti-inflammatory activity.

Pruzanski W, Stefanski E, Vadas P, Ramamurthy NS.

Biochem Pharmacol. 1997 Jun 15;53(12):1901-7.

PMID:
9256165
[PubMed - indexed for MEDLINE]
12.

Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes.

Triggiani M, Granata F, Oriente A, Gentile M, Petraroli A, Balestrieri B, Marone G.

Eur J Immunol. 2002 Jan;32(1):67-76.

PMID:
11754005
[PubMed - indexed for MEDLINE]
14.

Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2.

García Pastor P, De Rosa S, De Giulio A, Payá M, Alcaraz MJ.

Br J Pharmacol. 1999 Jan;126(1):301-11.

PMID:
10051149
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Suppression of murine endotoxic shock by sPLA2 inhibitor, indoxam, through group IIA sPLA2-independent mechanisms.

Yokota Y, Hanasaki K, Ono T, Nakazato H, Kobayashi T, Arita H.

Biochim Biophys Acta. 1999 May 18;1438(2):213-22.

PMID:
10320804
[PubMed - indexed for MEDLINE]
16.

[Phospholipase A2--from basic research to clinical reality].

Schoenberg MH, Mayer JM, Beger HG.

Chirurg. 1997 Nov;68(11):1112-8. Review. German.

PMID:
9518201
[PubMed - indexed for MEDLINE]
17.

sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised.

Chen D, Wei Y, Li X, Epstein S, Wolosin JM, Asbell P.

Exp Eye Res. 2009 May;88(5):880-8. doi: 10.1016/j.exer.2008.11.035. Epub 2008 Dec 16.

PMID:
19116146
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains.

Kennedy BP, Payette P, Mudgett J, Vadas P, Pruzanski W, Kwan M, Tang C, Rancourt DE, Cromlish WA.

J Biol Chem. 1995 Sep 22;270(38):22378-85.

PMID:
7673223
[PubMed - indexed for MEDLINE]
Free Article
19.

Novel group V phospholipase A2 involved in arachidonic acid mobilization in murine P388D1 macrophages.

Balboa MA, Balsinde J, Winstead MV, Tischfield JA, Dennis EA.

J Biol Chem. 1996 Dec 13;271(50):32381-4.

PMID:
8943302
[PubMed - indexed for MEDLINE]
Free Article
20.

Comparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritis.

Coulthard LG, Costello J, Robinson B, Shiels IA, Taylor SM, Woodruff TM.

Arthritis Res Ther. 2011 Mar 14;13(2):R42. doi: 10.1186/ar3278.

PMID:
21401925
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk